MassIVE MSV000088215

Partial Public

GNPS Uncovering Xenobiotics in the Dark Metabolome using Ion Mobility Spectrometry, Mass Defect Analysis and Machine Learning

Description

The identification of xenobiotics through nontargeted analysis is a vital step in understanding human exposure, however metabolism, excretion, and co-existence with other endogenous molecules in the metabolome greatly complicate their measurements. Xenobiotics are therefore commonly undetected and exist as part of the dark metabolome. While mass spectrometry (MS)-based platforms are commonly used in metabolomic measurements, deconvoluting endogenous metabolites and xenobiotics is often limited by a lack of xenobiotic parent and metabolite standards as well as the numerous isomers possible for each m/z feature. Here we evaluated the ability of ion mobility spectrometry (IMS) and mass defect filtering techniques to narrow large metabolomic feature lists to xenobiotics of interest. Due to the lack of IMS collision cross section (CCS) values for per- and polyfluoroalkyl substances (PFAS), we initially evaluated 87 PFAS standards with IMS-MS to develop a PFAS CCS library. The detected PFAS CCS and m/z values were then compared to other biomolecule and xenobiotic classes, illustrating clear differentiation between the biomolecules and the halogenated xenobiotics. To address the lack of xenobiotic standards, machine learning was then utilized to predict CCS values. Ultimately, a xenobiotic selection workflow combining experimental and theoretical CCS values and mass defect filtering was employed to evaluate PFAS features in NIST human serum. This workflow reduced the 2,423 LC-IMS-MS features to 98 possible PFAS, and 23 were identified using homologous series information. [doi:10.25345/C5FV9K] [dataset license: CC0 1.0 Universal (CC0 1.0)]

Keywords: Perfluoroalkyl Substances ; Polyfluoroalkyl Substances ; PFAS

Contact

Principal Investigators:
(in alphabetical order)
Erin Baker, North Carolina State University, United States
Submitting User: mrfoster
Number of Files:
Total Size:
Spectra:
Subscribers:
 
Owner Reanalyses
Experimental Design
    Conditions:
    Biological Replicates:
    Technical Replicates:
 
Identification Results
    Proteins (Human, Remapped):
    Proteins (Reported):
    Peptides:
    Variant Peptides:
    PSMs:
 
Quantification Results
    Differential Proteins:
    Quantified Proteins:
 
Browse Dataset Files
 
FTP Download Link (click to copy):

- Dataset Reanalyses


+ Dataset History


GNPS content goes here (MSV000088215 [task=2e56d6e15e9b4446a648aa0ee9f5c2b2])
Click here to queue conversion of this dataset's submitted spectrum files to open formats (e.g. mzML). This process may take some time.

When complete, the converted files will be available in the "ccms_peak" subdirectory of the dataset's FTP space (accessible via the "FTP Download" link to the right).
Number of distinct conditions across all analyses (original submission and reanalyses) associated with this dataset.

Distinct condition labels are counted across all files submitted in the "Metadata" category having a "Condition" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct biological replicates across all analyses (original submission and reanalyses) associated with this dataset.

Distinct replicate labels are counted across all files submitted in the "Metadata" category having a "BioReplicate" or "Replicate" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct technical replicates across all analyses (original submission and reanalyses) associated with this dataset.

The technical replicate count is defined as the maximum number of times any one distinct combination of condition and biological replicate was analyzed across all files submitted in the "Metadata" category. In the case of fractionated experiments, only the first fraction is considered.

"N/A" means no results of this type were submitted.
Originally identified proteins that were automatically remapped by MassIVE to proteins in the SwissProt human reference database.

"N/A" means no results of this type were submitted.
Number of distinct protein accessions reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct unmodified peptide sequences reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct peptide sequences (including modified variants or peptidoforms) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Total number of peptide-spectrum matches (i.e. spectrum identifications) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins quantified across all analyses (original submission and reanalyses) associated with this dataset.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins found to be differentially abundant in at least one comparison across all analyses (original submission and reanalyses) associated with this dataset.

A protein is differentially abundant if its change in abundance across conditions is found to be statistically significant with an adjusted p-value <= 0.05 and lists no issues associated with statistical tests for differential abundance.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
This dataset may not contain all raw spectra data as originally deposited in PRIDE. It has been imported to MassIVE for reanalysis purposes, so its spectra data here may consist solely of processed peak lists suitable for reanalysis with most software.